MA27542A1 - Compositions a delitement intra-oral, acceptables du point de vue organoleptique. - Google Patents
Compositions a delitement intra-oral, acceptables du point de vue organoleptique.Info
- Publication number
- MA27542A1 MA27542A1 MA27587A MA27587A MA27542A1 MA 27542 A1 MA27542 A1 MA 27542A1 MA 27587 A MA27587 A MA 27587A MA 27587 A MA27587 A MA 27587A MA 27542 A1 MA27542 A1 MA 27542A1
- Authority
- MA
- Morocco
- Prior art keywords
- compositions
- acceptable
- intra
- view
- oral delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Compositions à délitement intra-oral, acceptables du point de vue organoleptique Des comprimés à délitement oral, fondant rapidement, et des procédés pour la préparation de ces formes posologiques sont proposés. Les compositions sont utiles dans le traitement ou la prophylaxie d'une large gamme de troubles et d'affections.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32535601P | 2001-09-26 | 2001-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27542A1 true MA27542A1 (fr) | 2005-10-03 |
Family
ID=23267542
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA27587A MA27542A1 (fr) | 2001-09-26 | 2004-03-24 | Compositions a delitement intra-oral, acceptables du point de vue organoleptique. |
MA27586A MA27682A1 (fr) | 2001-09-26 | 2004-03-24 | Compositions de valdecoxib a delitement intra-oral |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA27586A MA27682A1 (fr) | 2001-09-26 | 2004-03-24 | Compositions de valdecoxib a delitement intra-oral |
Country Status (25)
Country | Link |
---|---|
US (1) | US20030181501A1 (fr) |
EP (2) | EP1429736A2 (fr) |
JP (2) | JP2005512964A (fr) |
KR (2) | KR20040044990A (fr) |
CN (2) | CN1633281A (fr) |
AP (2) | AP2004002998A0 (fr) |
AR (1) | AR037239A1 (fr) |
BR (2) | BR0212861A (fr) |
CA (2) | CA2461630A1 (fr) |
CO (2) | CO5570684A2 (fr) |
EA (2) | EA200400357A1 (fr) |
EC (1) | ECSP045029A (fr) |
GE (1) | GEP20063856B (fr) |
HK (1) | HK1079988A1 (fr) |
IL (2) | IL160855A0 (fr) |
IS (2) | IS7177A (fr) |
MA (2) | MA27542A1 (fr) |
MX (2) | MXPA04002798A (fr) |
NO (2) | NO20041258L (fr) |
OA (2) | OA12707A (fr) |
PL (2) | PL369297A1 (fr) |
TN (2) | TNSN04045A1 (fr) |
WO (2) | WO2003026623A1 (fr) |
YU (1) | YU34804A (fr) |
ZA (2) | ZA200401953B (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005002557A1 (fr) * | 2003-07-03 | 2005-01-13 | Warner-Lambert Company Llc | Compositions pharmaceutiques comprenant un ether et un inhibiteur selectif de la cyclooxygenase-2 et leur utilisations |
US20050186271A1 (en) * | 2004-02-24 | 2005-08-25 | Sheskey Paul J. | Process for dispersing a fluid in a mass of solid particles |
WO2006016602A1 (fr) * | 2004-08-10 | 2006-02-16 | Ajinomoto Co., Inc. | Préparation contenant du natéglinide dont l'amertume a été réduite |
EP1839650A1 (fr) * | 2004-12-28 | 2007-10-03 | Eisai R&D Management Co., Ltd. | Comprime a desintegration rapide et son procede de fabrication |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US20100015221A1 (en) * | 2005-12-20 | 2010-01-21 | Eisai R&D Management Co.Ltd. | Orally rapid disintegrating tablet preparation comprising fat-soluble active ingredients |
US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8202535B2 (en) | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
WO2007087188A2 (fr) * | 2006-01-20 | 2007-08-02 | Merck & Co., Inc. | Comprimes et granules au gout masque |
US20070196494A1 (en) * | 2006-02-17 | 2007-08-23 | Arnaud Grenier | Low-friability, patient-friendly orally disintegrating formulations |
WO2007142811A2 (fr) * | 2006-05-19 | 2007-12-13 | Somaxon Pharmaceuticals, Inc. | Formulations de doxépine à faible dose, incluant des formulations buccales, sublinguales et à dissolution rapide, et leurs utilisations pour traiter l'insomnie |
US8685457B2 (en) * | 2007-06-06 | 2014-04-01 | Basf Se | Pharmaceutical formulation for the production of rapidly disintegrating tablets |
ES2646112T3 (es) * | 2007-06-06 | 2017-12-12 | Basf Se | Formulación farmacéutica para la fabricación de comprimidos que se desintegran rápidamente |
CN101686931B (zh) * | 2007-06-06 | 2013-06-19 | 巴斯夫欧洲公司 | 用于制备可咀嚼片剂和锭剂的药物配制剂 |
AU2008258627A1 (en) * | 2007-06-06 | 2008-12-11 | Basf Se | Pharmaceutical formulation for the production of rapidly disintegrating tablets |
EP3269346A1 (fr) * | 2007-08-07 | 2018-01-17 | Acelrx Pharmaceuticals, Inc. | Dispositif d'administration orale de médicament |
US20110086070A1 (en) | 2008-03-24 | 2011-04-14 | Munish Talwar | Orally disintegrating compositions of rhein or diacerein |
US8945592B2 (en) * | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
CN103919742B (zh) * | 2008-11-25 | 2017-04-12 | 田边三菱制药株式会社 | 口腔速崩片及其制备方法 |
CA2765033C (fr) | 2009-06-12 | 2020-07-14 | Meritage Pharma, Inc. | Procedes de traitement de troubles gastro-intestinaux |
US20110091544A1 (en) * | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
FR2968995B1 (fr) * | 2010-12-16 | 2013-03-22 | Sanofi Aventis | Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage |
CN106822007B (zh) | 2015-09-11 | 2021-12-31 | 西姆莱斯股份公司 | 口服制剂 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5576014A (en) * | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
SK74396A3 (en) * | 1995-06-13 | 1997-04-09 | American Home Prod | Organoleptically acceptable oral pharmaceutical compositions |
WO1997014630A1 (fr) * | 1995-10-20 | 1997-04-24 | Pharmacia & Upjohn Company | Emballage blister |
BR9709097A (pt) * | 1996-05-17 | 1999-08-03 | Merck & Co Inc | Composição farmacêutica para o tratamento de doenças mediadas por ciclooxigenase processo para tratar uma doença inflamatória suscetível de tratamento com um agente antinflamatório n o esteróide uso e forma oral de dose unitária |
EP0863134A1 (fr) * | 1997-03-07 | 1998-09-09 | Merck Frosst Canada Inc. | 2-(3,5-difluorophényle)-3-(4-méthylesulphonylephényle)-2-cyclopentène-1-one comme inhibiteur de la cyclooxygénase-2 |
US6465009B1 (en) * | 1998-03-18 | 2002-10-15 | Yamanouchi Pharmaceutical Co., Ltd. | Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
WO2001041761A2 (fr) * | 1999-12-08 | 2001-06-14 | Pharmacia Corporation | Compositions de valdecoxib |
US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
US6800297B2 (en) * | 2000-06-15 | 2004-10-05 | Acusphere, Inc. | Porous COX-2 inhibitor matrices and methods of manufacture thereof |
CN1638739A (zh) * | 2000-08-18 | 2005-07-13 | 法玛西雅厄普约翰美国公司 | 治疗成瘾性障碍的化合物 |
ATE329583T1 (de) * | 2000-08-18 | 2006-07-15 | Pharmacia Corp | Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib |
-
2002
- 2002-09-23 IL IL16085502A patent/IL160855A0/xx unknown
- 2002-09-23 IL IL16084802A patent/IL160848A0/xx unknown
- 2002-09-23 BR BR0212861-6A patent/BR0212861A/pt not_active IP Right Cessation
- 2002-09-23 EP EP02773522A patent/EP1429736A2/fr not_active Withdrawn
- 2002-09-23 EP EP02775948A patent/EP1490035A1/fr not_active Withdrawn
- 2002-09-23 KR KR10-2004-7004373A patent/KR20040044990A/ko not_active Application Discontinuation
- 2002-09-23 MX MXPA04002798A patent/MXPA04002798A/es unknown
- 2002-09-23 PL PL02369297A patent/PL369297A1/xx not_active Application Discontinuation
- 2002-09-23 EA EA200400357A patent/EA200400357A1/ru unknown
- 2002-09-23 CN CNA028211413A patent/CN1633281A/zh active Pending
- 2002-09-23 GE GE5525A patent/GEP20063856B/en unknown
- 2002-09-23 US US10/252,222 patent/US20030181501A1/en not_active Abandoned
- 2002-09-23 WO PCT/US2002/030161 patent/WO2003026623A1/fr active Application Filing
- 2002-09-23 PL PL02369298A patent/PL369298A1/xx not_active Application Discontinuation
- 2002-09-23 EA EA200400352A patent/EA200400352A1/ru unknown
- 2002-09-23 MX MXPA04002652A patent/MXPA04002652A/es unknown
- 2002-09-23 KR KR10-2004-7004334A patent/KR20040058189A/ko not_active Application Discontinuation
- 2002-09-23 OA OA1200400083A patent/OA12707A/en unknown
- 2002-09-23 AP APAP/P/2004/002998A patent/AP2004002998A0/en unknown
- 2002-09-23 JP JP2003530260A patent/JP2005512964A/ja not_active Withdrawn
- 2002-09-23 OA OA1200400082A patent/OA13060A/en unknown
- 2002-09-23 BR BR0212778-4A patent/BR0212778A/pt not_active IP Right Cessation
- 2002-09-23 YU YU34804A patent/YU34804A/sh unknown
- 2002-09-23 JP JP2003530331A patent/JP2005506987A/ja not_active Withdrawn
- 2002-09-23 CA CA002461630A patent/CA2461630A1/fr not_active Abandoned
- 2002-09-23 CN CNA028189078A patent/CN1703203A/zh active Pending
- 2002-09-23 AP APAP/P/2004/002999A patent/AP2004002999A0/en unknown
- 2002-09-23 CA CA002461044A patent/CA2461044A1/fr not_active Abandoned
- 2002-09-23 WO PCT/US2002/030048 patent/WO2003026697A2/fr active Application Filing
- 2002-09-26 AR ARP020103627A patent/AR037239A1/es unknown
-
2004
- 2004-03-10 ZA ZA200401953A patent/ZA200401953B/en unknown
- 2004-03-11 IS IS7177A patent/IS7177A/is unknown
- 2004-03-11 IS IS7178A patent/IS7178A/is unknown
- 2004-03-23 EC EC2004005029A patent/ECSP045029A/es unknown
- 2004-03-23 TN TNP2004000045A patent/TNSN04045A1/fr unknown
- 2004-03-24 MA MA27587A patent/MA27542A1/fr unknown
- 2004-03-24 MA MA27586A patent/MA27682A1/fr unknown
- 2004-03-24 TN TNP2004000047A patent/TNSN04047A1/fr unknown
- 2004-03-25 ZA ZA200402364A patent/ZA200402364B/xx unknown
- 2004-03-25 NO NO20041258A patent/NO20041258L/no not_active Application Discontinuation
- 2004-03-26 CO CO04028409A patent/CO5570684A2/es not_active Application Discontinuation
- 2004-03-26 CO CO04028410A patent/CO5570659A2/es not_active Application Discontinuation
- 2004-04-15 NO NO20041532A patent/NO20041532L/no not_active Application Discontinuation
-
2006
- 2006-01-04 HK HK06100055.6A patent/HK1079988A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27542A1 (fr) | Compositions a delitement intra-oral, acceptables du point de vue organoleptique. | |
FR2727016B1 (fr) | Compositions pharmaceutiques a base d'ondansetron | |
AR020015A1 (es) | Composiciones de celecoxib | |
IL116083A0 (en) | Liquid pharmaceutical compositions containing ondansetron and their use | |
CA2427227A1 (fr) | Compose de lactam | |
BG105302A (en) | Means for improving cognition | |
HUP0402178A2 (hu) | 5 HT1 antagonista hatóanyagot tartalmazó gyógyszerkészítmény | |
HUP0204511A2 (en) | Use of ppar activator or ligand in preparation of pharmaceutical compositions for treatment of bone diseas | |
WO2002055062A3 (fr) | Comprime pharmaceutique comprenant du mesylate de paroxetine | |
MA27543A1 (fr) | Compositions de valdecoxib a delitement intra-oral preparees par un procede de sechage par pulverisation. | |
DK1448184T3 (da) | Anvendelse af propionyl-L-carnitin eller et af dets farmakologisk acceptable salte til fremstilling af en medicin til behandling af Peyronies sygdom | |
HUP0301847A2 (hu) | Adatanszerin alkalmazása neurodegeneratív állapotok megelżzésére és kezelésére alkalmas gyógyszerkészítmények elżállítására | |
CA2205600A1 (fr) | Compositions d'ondansetron lyophilisees |